- Home
- BDX vs TAK Comparison
BDX vs TAK Comparison
Compare BDX & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDX
- TAK
- Stock Information
- Founded
- BDX 1897
- TAK 1781
- Country
- BDX United States
- TAK Japan
- Employees
- BDX N/A
- TAK N/A
- Industry
- BDX Medical/Dental Instruments
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- BDX Health Care
- TAK Health Care
- Exchange
- BDX Nasdaq
- TAK Nasdaq
- Market Cap
- BDX 49.0B
- TAK 45.8B
- IPO Year
- BDX 1962
- TAK N/A
- Fundamental
- Price
- BDX $175.90
- TAK $14.68
- Analyst Decision
- BDX Buy
- TAK
- Analyst Count
- BDX 9
- TAK 0
- Target Price
- BDX $231.50
- TAK N/A
- AVG Volume (30 Days)
- BDX 2.7M
- TAK 2.2M
- Earning Date
- BDX 08-07-2025
- TAK 07-30-2025
- Dividend Yield
- BDX 2.36%
- TAK 3.70%
- EPS Growth
- BDX 14.07
- TAK N/A
- EPS
- BDX 5.16
- TAK 0.45
- Revenue
- BDX $20,867,000,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- BDX $9.26
- TAK $1.01
- Revenue Next Year
- BDX $4.87
- TAK $1.04
- P/E Ratio
- BDX $34.08
- TAK $65.09
- Revenue Growth
- BDX 5.84
- TAK 7.45
- 52 Week Low
- BDX $163.33
- TAK $12.80
- 52 Week High
- BDX $251.99
- TAK $15.53
- Technical
- Relative Strength Index (RSI)
- BDX 53.25
- TAK 41.31
- Support Level
- BDX $172.34
- TAK $14.93
- Resistance Level
- BDX $179.76
- TAK $15.14
- Average True Range (ATR)
- BDX 3.34
- TAK 0.15
- MACD
- BDX 0.84
- TAK -0.06
- Stochastic Oscillator
- BDX 68.52
- TAK 11.86
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.